FEATURES

DESCRIPTION

Also known as OLR1_HUMAN, OLR1, CLEC8A, LOX1. Receptor that mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (oxLDL) by vascular endothelial cells. OxLDL is a marker of atherosclerosis that induces vascular endothelial cell activation and dysfunction, resulting in pro-inflammatory responses, pro-oxidative conditions and apoptosis. Its association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular responses including a reduction of nitric oxide (NO) release, monocyte adhesion and apoptosis. In addition to binding oxLDL, it acts as a receptor for the HSP70 protein involved in antigen cross-presentation to naive T-cells in dendritic cells, thereby participating in cell-mediated antigen cross-presentation. Also involved in inflammatory process, by acting as a leukocyte-adhesion molecule at the vascular interface in endotoxin-induced inflammation. Also acts as a receptor for advanced glycation end (AGE) products, activated platelets, monocytes, apoptotic cells and both Gram-negative and Gram-positive bacteria., (Microbial infection) May serve as a receptor for adhesin A variant 3 (nadA) of N.meningitidis. Homodimer; disulfide-linked. May form a hexamer composed of 3 homodimers. Interacts with HSP70.

EXTERNAL LINKS

OLR1

Oxidized low-density lipoprotein receptor 1

OLR1

Molecular Synopsis